Abstract
Acquisition of the metastatic potential involves participation of various cellular properties, in addition to those required for the transforming process. The metastatic cells must depart from the primary tumor, invade surrounding matrix, intravasate lymphatics and blood vessels, survive mechanical trauma of the circulation, resist cytotoxic immune cells, extravasate, and finally proliferate in a distant organ. Considerable progress has been made in identifying different enzymatic and surface properties of tumor cells that are associated with the metastatic phenotype. However, with the techniques available in the past to study the genetic aspect of metastasis no specific genetic determinants have been found. Most studies have involved assessing the inheritability of the overall metastatic phenotype, using somatic cell hybridization technique where normal cells and tumor cells, or nonmetastatic and metastatic cells have been fused. Most of the cell hybridization studies have demonstrated that both the tumorigenic and the metastatic phenotypes behave as recessive traits (28, 44, 56).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albini A, Iwamoto Y, Kleinman HK, et al: Rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239–3245, 1987
Bernstein SC, Weinberg RA: Expression of the metastatic phenotype in cells transfected with human metastatic tumor DNA. Proc Natl Acad Sci USA 82:1726–1730, 1985
Biedler JL, Spengler BA: A novel chromosome abnormality in human neuroblastoma and antifolate-resistant Chinese hamster cell lines in culture. JNCI 57:683–695, 1976
Bishop JM: Cellular oncogenes and retroviruses. Annu Rev Biochem 52:301–354, 1983
Brodeur GM, Seeger RC, Schwab M, et al: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121–1124, 1984
Capon DJ, Seeburg PH, McGrath JP, et al: Activation of Ki-ras 2 gene in human colon and lung carcinomas by two different point mutations. Nature 304: 507–513, 1983
Coffin JM, Varmus HE, Bishop JM, et al: Proposal for naming host cell-derived inserts in retrovirus genomes. J Virol 40:953–957, 1981
Cooper GM: Cellular transforming genes. Science 218:801–806, 1982
Cowell JK: Double minutes and homogeneously staining regions: gene amplification in mammalian cells. Annu Rev Genet 16:21–59, 1982
Dalla-Favera R, Westin E, Gelman EP, et al: The human onc gene c-myc: structure, expression, and amplification in the human promyelocytic leukemia cell line HL-60. Hematol Bluttransfus 28:247–254, 1983
DeFeo-Jones D, Scolnick EM, Koller R, et al: Ras related sequences identified and isolated from Saccharomyces cerevisiae. Nature 306:707–709, 1983
Der CJ, Krontiris TG, Cooper GM: Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 79:3637–3640, 1982
Doolittle RF, Hunkapiller MW, Hood LE, et al: Simian sarcoma virus one gene v-sis is derived from the gene (or genes) encoding a platelet derived growth factor. Science 221:275–277, 1983
Downward J, Yarden Y, Mayes E, Scarce G, et al: Close similarity of epidermal growth factor and v-erb oncogene protein sequences. Nature 307:521–527, 1984
Easty DM, Easty GC: An in vitro model for studying cell invasiveness. In: Organ Culture in Biochemical Research. M Balls, MA Monnickendam (eds). pp. 379–392. Cambridge Univ. Press, Cambridge, 1976
Eccles SA, Marshall CJ, Vousden K, et al: Enhanced spontaneous metastatic capacity of mammary carcinoma cells transfected with H-ras. In: Treatment of Metastasis: Problems and Prospects. K Hellman, SA Eccles (eds). pp. 385–388. Taylor & Francis, London, 1985
Eva A, Robbins KC, Andersen PR, et al: Cellular genes analogous to retroviral one genes are transcribed in human tumor cells. Nature 295:116–119, 1982
Fidler IJ: The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer 9:223–227, 1973
Graham FL, van der Eb AJ: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 53:456–467, 1973
Greig RG, Koestler TP, Trainer DL, et al: Tumorigenic and metastatic properties of “normal” and ras-transfected NIH/ 3T3 cells. Proc Natl Acad sci USA 82:3698–3701, 1985
Hamlyn PH, Rabbitts TH: Translocation joins c-myc and immunoglobulin genes in a Burkitt’s lymphoma revealing a third exon in the c-myc oncogene. Nature 304:135–139, 1983
Hart IR, Fidler IJ: An in vitro quantitative assay for tumor cell invasion. Cancer Res 38:3218–3224, 1978
Hart IR, Talmadge JE, Fidler IJ: Comparative studies on the quantitative analysis of experimental metastatic capacity. Cancer Res 43:400–402, 1983
Jones PA: Construction of an artificial blood vessel wall from cultured endothelial and smooth muscle cells. Proc Natl Acad sci USA 76:1882–1886, 1979
Kleinman HK, McGarvey ML, Hassell JR, et al: Basement membrane complexes with biological activity. Biochemistry 25:312–318, 1986
Kohl NE, Kanda N, Schreck RR, et al: Transposition and amplification of oncogene-related sequences in human neuroblastoma. Cell 35:359–367, 1983
Land H, Parada LF, Weinberg RA: Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596–602, 1983
Larizza L, Schirrmacher V: Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants. Cancer Metastasis Rev 3:193–222, 1984
Liotta LA, Saidel GM, Kleinerman J: The significance of hematogenous cell clumps in the metastatic process. Cancer Res 36:889–894, 1976
Liotta LA, Tryggvason K, Garbisa S, et al: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67–68, 1980
Little CD, Nau MM, Carney DN, et al: Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306:194–196, 1983
Maignan MF: Etude ultrastructurale des interactions entre des cellules normales ou malignes et le sac vitellin de Rat, explante in vitro. Biol Cellulaire 35:229–232, 1979
Mareel M, De Ridder L, De Brabander M, et al: Characterization of spontaneous, chemical, and viral transformants of a C3H/3T3-type mouse cell line by transplantation into young chick blastoderms. JNCI 54:923–929, 1975
Mareel M, Kint J, Meyvish C: Methods of study of the invasion of malignant C3H-mouse fibroblasts into embryonic chick heart in vitro. Virch Arch (Cell Pathol) 30:95–111, 1979
Muller R, Verma IM: Expression of cellular oncogenes. Curr Top Microbiol Immunol 112:73–115, 1984
Murray MJ, Cunningham JM, Parada LF, et al: The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors. Cell 33:749–757, 1983
Muschel RJ, Williams JE, Lowy DR, et al: Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cells. Am J Pathol 121:1–8, 1985
Nakano H, Yamamoto F, Neville C, et al: Isolation of transforming sequences of two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes. Proc Natl Acad sci USA 81:71–75, 1984
Noguchi PD, Johnson JB, O’Donnell R, et al: Chick embryonic skin as a rapid organ culture assay for cellular neoplasia. Science 199:980–983, 1978
Nowell P, Finan J, Dalla Favera R, et al: Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukemia cell line. Nature 306:494–497, 1983
Pauli BU, Anderson SN, Memoli VA, et al: Development of an in vitro and in vivo epithelial tumor model for the study of invasion. Cancer Res 40:4571–4580, 1980
Poste G, Doll J, Hart IR, et al: In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res 40:1636–1644, 1980
Pourreau-Schneider N, Felix H, Haemmrli G, et al: The role of cellular locomotion in leukemic infiltration: An organ culture study on penetration of L5222 rat leukemia cells into chick embryomesonephros. Virch Arch B (Cell Pathol) 23:257–264, 1977
Ramshaw IA, Carlsen S, Wang HC, et al: The use of cell fusion to analyze factors involved in tumor cell metastasis. Int J Cancer 32:471–478, 1983
Reddy EP, Reynolds RK, Santos E, et al: A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300:149–152, 1982
Russo RG, Thorgeirsson UP, Liotta LA: In vitro quantitative assay of invasion using human amnion. In: Tumor Invasion and Metastasis. LA Liotta, Hart IR (eds). pp. 173–187. Martinus Nijhoff, The Hague, 1982
Saksela K, Bergh J, Lehto VP, et al: Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. Cancer Res 45:1823–1827, 1985
Santos E, Reddy EP, Pulciani S, et al: Spontaneous activation of a human proto-oncogene. Proc Natl Acad sci USA 80:4679–4683, 1983
Scher C, Haudenschild C, Klagsbrun M: The chick chorioallantoic membrane as a model system for the study of tissue invasion by viral transformed cells. Cell 8:373–382, 1976
Schirrmacher V, Shantz G, Claurer K, et al: Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastases formation in vivo. Int J Cancer 23:233–244, 1979
Schleich AB, Frich M, Mayer A: Patterns of invasive growth in vitro. Human decidua graviditatis confronted with established human cell lines and primary human explants. JNCI 56:221–237, 1976.
Shibuya M, Yokota J, Ueyama Y: Amplification and expression of a cellular oncogene (c-myc) in human gastric adenocarcinoma cells. Mol Cell Biol 5:414–418, 1985
Shih C, Padhy LC, Murray MJ, et al: Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290:261–264, 1981
Shilo BZ, Weinberg RA: DNA sequences homologous to vertebrate oncogenes are conserved in Drosophila melanogas-ter. Proc Natl Acad sci USA 78:6789–6792, 1981
Shimizu K, Birnbaum D, Ruley MA, et al: Straucture of the Ki-ras gene of the human lung carcinoma cell calu-1. Nature 304:497–500, 1983
Straus DS, Jonasson J, Harris H: Growth in vitro of tumor cell x fibroblast hybrids in which malignancy is suppressed. J Cell sci 25:73–86, 1976
Sukumar S, Notario V, Martin-Zanca D, et al: Induction of mammary carcinomas in rats by nitroso-methyl-urea involves malignant activation of H-ras-1 locus by single point mutations. Nature 306:658–661, 1983
Taparowsky E, Shimizu K, Goldfarb M, et al: Structure and activation of the human N-ras gene. Cell 34:581–586, 1983
Thorgeirsson UP, Liotta LA, Kalebic T, et al: Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. JNCI 69:1049–1054, 1982
Thorgeirsson UP, Turpeenniemi-Hujanen T, Williams JE, et al: NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 5:259–262, 1985a
Thorgeirsson UP, Turpeenniemi-Hujanen T, Talmadge JE, et al: Expression of oncogenes in cancer metastasis. In: Cancer Metastasis: Experimental and Clinical Strategies. Welch DR, Bhuyan BK, Liotta LA (eds). pp. 77–93. Progress in Clinical and Biological Research Vol 212. Alan R. Liss, Inc., New York, 1986
Tickle C, Crawley A, Goodman M: Cell movement and the mechanism of invasiveness: A survey of the behaviour of some normal and malignant cells implanted into the developing chick wing bud. J Cell sci 31:293–322, 1978
Turpeenniemi-Hujanen T, Thorgeirsson UP, Hart IR, et al: Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cells hybrids which differ in metastatic potential. JNCI 75:99–103, 1985
Waterfield MD, Scarce GT, Whittle N, et al: Platelet derived growth factor is structurally related to the putative transforming protein p28 sis of simian sarcoma virus. Nature 304:35–39, 1983
Westin EH, Wong-Staal F, Gelmann EP, et al: Expression of cellular homologues of retroviral one genes in human hematopoietic cells. Proc Natl Acad sci USA 79:2490–2494, 1982
Wolman SR: Karyotypic progression in human tumors. Cancer Met Rev 2:257–293, 1983
Yuasa Y, Srivastava SK, Dunn CY, et al: Acquisition of transforming properties by alternative point mutations with c-bas/has human proto-oncogene. Nature 303:775–779, 1983.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers, Dordrecht
About this chapter
Cite this chapter
Thorgeirsson, U.P., Turpeenniemi-Hujanen, T., Ballin, M., Liotta, L.A. (1989). Methods to Study Ras Oncogene-Mediated Induction of the Metastatic Phenotype. In: Weisburger, E.K. (eds) Mechanisms of Carcinogenesis. Cancer Growth and Progression, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2526-7_14
Download citation
DOI: https://doi.org/10.1007/978-94-009-2526-7_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7641-8
Online ISBN: 978-94-009-2526-7
eBook Packages: Springer Book Archive